World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
11647
World Ranking
3165
National Ranking
269

Overview

Stephen Jolles is affiliated with the University Hospital of Wales in the United Kingdom. Their research primarily concentrates on medicine, with a substantial focus on immunology and microbiology. The scientist's work encompasses various subfields, including immunology, infectious diseases, genetics, hematology, and epidemiology.

Their research topics cover a spectrum of immunological and clinical concerns. Key areas of focus include immunodeficiency and autoimmune disorders, COVID-19 clinical research studies, SARS-CoV-2 and COVID-19 research, blood disorders and treatments, chronic lymphocytic leukemia research, platelet disorders and treatments, and the broader impacts of COVID-19 on healthcare systems.

Stephen Jolles's frequently published papers include:

  • Coronavirus disease 2019 in patients with inborn errors of immunity: An international study (2020) in the Journal of Allergy and Clinical Immunology
  • COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience (2020) in the Journal of Allergy and Clinical Immunology
  • COVID -19 Vaccine Response in People with Multiple Sclerosis (2021) in Annals of Neurology
  • Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations (2020) in the Journal of Allergy and Clinical Immunology
  • Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia (2020) in Blood Advances

Stephen Jolles has published frequently in several venues, with the highest number of publications appearing in the Journal of Clinical Immunology, followed by the Journal of Allergy and Clinical Immunology, bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, and Current Opinion in Allergy and Clinical Immunology.

They collaborate regularly with other researchers, including Mark Ponsford, Andrew R. Gennery, Siobhan O. Burns, Sinisa Savic, and Emma Tallantyre.

Best Publications

  • BSACI guidelines for the management of allergic and non‐allergic rhinitis

    G. K. Scadding;S. R. Durham;R. Mirakian;N. S. Jones

  • Clinical uses of intravenous immunoglobulin

    S. Jolles;W. A. C. Sewell;S. A. Misbah

  • Coronavirus Disease 2019 in patients with inborn errors of immunity: an international study.

    Isabelle Meyts;Giorgia Bucciol;Isabella Quinti;Bénédicte Neven

  • Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

    Asbjørg Stray-Pedersen;Hanne Sørmo Sorte;Pubudu Samarakoon;Tomasz Gambin;Tomasz Gambin

  • Whole-genome sequencing of a sporadic primary immunodeficiency cohort

    Thaventhiran Jed.;H Lango Allen;O S Burren;W Rae

  • The evolution of cellular deficiency in GATA2 mutation

    Rachel E. Dickinson;Paul Milne;Laura Jardine;Sasan Zandi

  • Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

    Paul Tuijnenburg;Hana Lango Allen;Hana Lango Allen;Siobhan O. Burns;Daniel Greene;Daniel Greene

  • Immunomodulatory action of intravenous immunoglobulin

    W. A. C. Sewell;S. Jolles

  • The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study.

    Peter Kiessling;Rocio Lledo-Garcia;Shikiko Watanabe;Grant Langdon

  • COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.

    Adrian M. Shields;Siobhan O. Burns;Siobhan O. Burns;Sinisa Savic;Alex G. Richter

  • The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.

    Smita Y. Patel;Javier Carbone;Stephen Jolles

  • International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency

    H Farkas;I Martinez-Saguer;K Bork;T Bowen

  • Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)

    Pranesh K. Chakraborty;Klaus Schmitz-Abe;Erin K. Kennedy;Hapsatou Mamady

  • Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry

    Maria Elena Maccari;Hassan Abolhassani;Hassan Abolhassani;Asghar Aghamohammadi;Alessandro Aiuti

  • Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.

    S. Jolles;J. S. Orange;A. Gardulf;M. R. Stein

  • British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders

    John R. Hurst;Nisha Verma;David Lowe;Helen E. Baxendale

  • Dermatological uses of high-dose intravenous immunoglobulin.

    Stephen Jolles;Jenny Hughes;Sean Whittaker

  • Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2

    Hasan Hashem;Ashish R. Kumar;Ingo Müller;Florian Babor

  • Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases

    Sira Nanthapisal;Claire Murphy;Ebun Omoyinmi;Ying Hong

  • Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.

    H.-P. Hartung;L. Mouthon;R. Ahmed;S. Jordan

  • When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach

    Stephen Jolles;H. Chapel;J. Litzman

  • The variable in common variable immunodeficiency: a disease of complex phenotypes.

    Stephen Jolles

  • Current understanding and future directions

    Stephen Jolles;S. V. Kaveri;J. Orange

Frequent Co-Authors

Siobhan O. Burns
Siobhan O. Burns University College London
Andrew R. Gennery
Andrew R. Gennery Newcastle University
Jordan S. Orange
Jordan S. Orange University of Pennsylvania
Michael Borte
Michael Borte Leipzig University
Bodo Grimbacher
Bodo Grimbacher University of Freiburg
Sinisa Savic
Sinisa Savic University of Leeds
Mario Abinun
Mario Abinun Newcastle University
Mary Slatter
Mary Slatter Newcastle University
Hilary Longhurst
Hilary Longhurst Auckland District Health Board
Isabella Quinti
Isabella Quinti Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various advanced healthcare careers, particularly in nursing specialties. Many students begin their journey by exploring the best online RN programs for non nurses, which provide foundational knowledge for those transitioning into the nursing field.

For those already in nursing, an accelerated FNP program offers a fast track to becoming a Family Nurse Practitioner, a role that frequently intersects with immunological knowledge to manage patient care effectively.

Experienced FNPs considering specialization can benefit from learning how to make a smooth FNP to acute care NP transition, shifting focus toward acute and critical care environments where immunology expertise is crucial.

Understanding the financial prospects is also vital. Exploring the highest paid DNP specialties can help guide career decisions, ensuring alignment between passion for immunology and rewarding opportunities.

Best Scientists Citing Stephen Jolles

Trending Scientists

Recently Published Articles